Argent BioPharma Limited (LON:MXC – Get Free Report) shares rose 4.8% during mid-day trading on Tuesday . The stock traded as high as GBX 22 ($0.28) and last traded at GBX 22 ($0.28). Approximately 264 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 26,353 shares. The stock had previously closed at GBX 21 ($0.27).
Argent BioPharma Trading Up 4.8 %
The firm has a market capitalization of £9.65 million, a P/E ratio of -13.25 and a beta of 1.03. The company has a 50 day moving average of GBX 22 and a 200-day moving average of GBX 21.73.
About Argent BioPharma
MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia.
Further Reading
- Five stocks we like better than Argent BioPharma
- The Role Economic Reports Play in a Successful Investment Strategy
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- EV Stocks and How to Profit from Them
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What Does a Stock Split Mean?
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Argent BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Argent BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
